Новини

New research presented at the European Academy of Dermatology and Venerology (EADV) 30th Congress reveals COVID-19 vaccine hesitancy in psoriasis and psoriatic arthritis patients is being driven by concerns about vaccine safety and aggravation of their underlying condition.

In a second study, also reported at EADV Congress, researchers found no associations between biological therapies and the risk of respiratory tract infections (RTI) or serious infections (SI), including COVID-19.

The findings from both of these studies provide valuable insights for educating and supporting psoriasis patients with regards to the impact of biological treatments on infection, and on the need for COVID-19 vaccinations.

A new prototype device that can be used at home to treat basal cell carcinoma (a type of skin cancer) significantly reduces pain, while achieving efficacy comparable with a hospital stay. These findings come from a breakthrough pilot study, presented today at the 30th European Association of Dermatology and Venerology (EADV) Congress.

 

New research presented today at the European Academy of Dermatology and Venerology (EADV) 30th Congress reveals a link between genital warts and the human leukocyte antigen (HLA) system - the part of the immune system which helps regulate immune responses. This exciting breakthrough sets a new path for potential mRNA vaccinations against HPV and other sexually transmitted diseases.

The researchers in Denmark identified 12 protective and seven risk gene variants in the HLA system of 65,791 blood donors that influence risk of genital warts.

Individuals with risk alleles were found to be less successful at recognising the HPV virus and therefore more likely to present with genital warts

Researcher Dr Pernille Lindsø Andersen, PhD Fellow, Department of Clinical Immunology and Department of Dermatology at Zealand University Hospital, Denmark

 

 

A study on the characteristic differences of chronic spontaneous urticaria (commonly presented as hives) has been found to be less severe in children than in adults, with lower rates of angioedema and thyroid autoimmunity.

Findings of the study include shorter disease duration (10.0±18.2), lower occurrence of angioedema (21.8% vs 59.8%; p<0.001) and thyroid autoimmunity (8.9% vs 25.4%; <0.001) in the paediatric group vs. adult group. Moreover, paediatric CSU patients were found to respond better to antihistamines than adult CSU patients.

“Our research is focused on identifying these differences to help inform future treatment of chronic spontaneous urticaria and to provide more information on the effects of CSU on children – something which has previously been neglected in this field of research” shares Professor Emek Kocaturk, Koc University Hospital in Istanbul, Turkey.